SHIKARI® Q-TRAS


Enzyme immunoassay for the quantitative determination of Trastuzumab (Herceptin®, Herclon®).

Enzyme immunoassay for the quantitative determination of free Trastuzumab (Herclon®, Herceptin®) in serum and plasma. Matriks Biotek trastuzumab ELISA has been developed for the quantitative analysis of free trastuzumab in serum and plasma samples at high specificity.



Click the diagram to see bigger

about-me





Required Volume (µl) 10
Total Time (min) 70
Sample Serum, plasma
Sample Number 96
Detection Limit (ng/mL) 2
Spike Recovery (%) Between 85-115
Shelf Life (year) 1

SHIKARI® S-ATT


Enzyme immunoassay for the quantitative determination of antibodies to Trastuzumab (Herceptin®, Herclon®) in serum and plasma.

The Matriks Biotek Antibody to Trastuzumab (Herceptin®, Herclon®) Enzyme-Linked-Immuno-Sorbent-Assay (ELISA) Kit is intended for the qualitative determination of antibodies to Trastuzumab (Herceptin®, Herclon®) in serum and plasma.



Click the diagram to see bigger

about-me





Required Volume (µl) 20
Total Time (min) 140
Sample Serum, plasma
Sample Number 96
Detection Limit (ng/mL) 30
Spike Recovery (%) Between 85-115
Shelf Life (year) 1
   

PEER REVIEWED JOURNAL ARTICLES:

Jonathan GG, Beatriz AÁ, Nazco C GJ, Norberto BL, Fernando GN. Plasma levels of trastuzumab in gastric cancer: Case report. J Oncol Pharm Pract. Sep 23, 2016.**

** Open Access


MATRIKS BIOTECHNOLOGY CO., LTD

Gazi Üniversitesi Gölbaşı Yerleşkesi Teknoplaza Binası,
(B Blok Zemin Kat BZ17),
06830,
Gölbaşı/ANKARA/TÜRKİYE

Contact Details

Telephone: +90 (312) 485 42 94
Email: info@matriksbiotek.com
Fax: +90 (312) 485 11 87